Arbor Pharmaceuticals, LLC.-Product Pipeline Review-2015

Arbor Pharmaceuticals, LLC.-Product Pipeline Review-2015

  • Products Id :- GMDHC07083CDB
  • |
  • Pages: 18
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Arbor Pharmaceuticals, LLC.-Product Pipeline Review-2015


Global Markets Direct's, 'Arbor Pharmaceuticals, LLC.-Product Pipeline Review-2015', provides an overview of the Arbor Pharmaceuticals, LLC.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Arbor Pharmaceuticals, LLC. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Arbor Pharmaceuticals, LLC.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Arbor Pharmaceuticals, LLC.'s pipeline products

Reasons To Buy

Evaluate Arbor Pharmaceuticals, LLC.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Arbor Pharmaceuticals, LLC. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Arbor Pharmaceuticals, LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Arbor Pharmaceuticals, LLC. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arbor Pharmaceuticals, LLC.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Arbor Pharmaceuticals, LLC. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Arbor Pharmaceuticals, LLC. Snapshot 4

Arbor Pharmaceuticals, LLC. Overview 4

Key Information 4

Key Facts 4

Arbor Pharmaceuticals, LLC.-Research and Development Overview 5

Key Therapeutic Areas 5

Arbor Pharmaceuticals, LLC.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Arbor Pharmaceuticals, LLC.-Pipeline Products Glance 9

Arbor Pharmaceuticals, LLC.-Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Phase I Products/Combination Treatment Modalities 10

Arbor Pharmaceuticals, LLC.-Drug Profiles 11

AR-08 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

AR-06 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

AR-18 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Arbor Pharmaceuticals, LLC.-Pipeline Analysis 14

Arbor Pharmaceuticals, LLC.-Pipeline Products by Route of Administration 14

Arbor Pharmaceuticals, LLC.-Recent Pipeline Updates 15

Arbor Pharmaceuticals, LLC.-Locations And Subsidiaries 16

Head Office 16

Appendix 17

Methodology 17

Coverage 17

Secondary Research 17

Primary Research 17

Expert Panel Validation 17

Contact Us 17

Disclaimer 18

List of Tables

Arbor Pharmaceuticals, LLC., Key Information 4

Arbor Pharmaceuticals, LLC., Key Facts 4

Arbor Pharmaceuticals, LLC.-Pipeline by Indication, 2015 6

Arbor Pharmaceuticals, LLC.-Pipeline by Stage of Development, 2015 7

Arbor Pharmaceuticals, LLC.-Monotherapy Products in Pipeline, 2015 8

Arbor Pharmaceuticals, LLC.-Phase II, 2015 9

Arbor Pharmaceuticals, LLC.-Phase I, 2015 10

Arbor Pharmaceuticals, LLC.-Pipeline by Route of Administration, 2015 14

Arbor Pharmaceuticals, LLC.-Recent Pipeline Updates, 2015 15

List of Figures

Arbor Pharmaceuticals, LLC.-Pipeline by Top 10 Indication, 2015 6

Arbor Pharmaceuticals, LLC.-Pipeline by Stage of Development, 2015 7

Arbor Pharmaceuticals, LLC.-Monotherapy Products in Pipeline, 2015 8

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Arbor Pharmaceuticals, LLC.; Arbor Pharmaceuticals, LLC. - Key Therapeutics; Arbor Pharmaceuticals, LLC. - Pipeline Overview and Promising Molecules; Arbor Pharmaceuticals, LLC. - News; Arbor Pharmaceuticals, LLC. - Latest Updates; Arbor Pharmaceuticals, LLC. - Pipeline; Arbor Pharmaceuticals, LLC. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97380
Site License
USD 3000 INR 194760
Corporate User License
USD 4500 INR 292140



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]